Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in Mouse Model

Liuweiwuling Tablet (LWWL) is a licensed Chinese patent medicine (approval number: Z20060238) included in the national health insurance for anti-inflammation of chronic HBV infection, whereas its anti-HBV effect remains clarification. The study aimed to clarify its antiviral effect and related mecha...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Fei-lin, Si, Lan-lan, Yang, Yan, Li, Yuan-hua, Lv, Zhong-lin, Liu, Wen-hui, Liao, Hao, Wang, Jun, Zou, Jun, Li, Le, Li, Hui, Zhang, Zi-lin, Wang, Jia-bo, Lu, Xue-chun, Xu, Dong-ping, Bai, Zhao-fang, Liu, Yan, Xiao, Xiao-he
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578813/
https://www.ncbi.nlm.nih.gov/pubmed/34776974
http://dx.doi.org/10.3389/fphar.2021.756975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578813/
https://www.ncbi.nlm.nih.gov/pubmed/34776974
http://dx.doi.org/10.3389/fphar.2021.756975

Ejemplares similares